Hepatitis C virus prevalence and serotypes associated with HIV in the Gambia

British Journal of Biomedical Science

Volumn 67, Issue 3, 2010, Pages 140-144

  Mboto, C I ^a   Fielder, M ^b   Davies Russell, A ^b   Jewell, A P ^b  

^a Royal Victoria Teaching Hospital Gambia   (Gambia)

^b KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

Hepatitis C; HIV; Prevalence; Serotyping

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY SCREENING; ARTICLE; AUSTRALIA; BLOOD DONOR; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMBIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; INFANT; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; SEROTYPE; TEACHING HOSPITAL;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77957011485     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2010.11730311     Document Type: Article

References (26)

1. Pawlotsky JM, Roudot-Thoraval F, Bastie A et al. Factors affecting treatment responses to interferon-α in chronic hepatitis C. J Infect Dis 1996; 174: 1-7. (Pubitemid 26255548)
2. Haushofer AC, Kopty C, Hauer R, Brunner H, Halbmayer WM. HCV genotypes and age distribution in patients of Vienna and surrounding areas. J Clin Virol 2001; 20 (1-2): 41-7.
3. Hnatyszyn HJ. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther 2005; 10 (1): 1-11. (Pubitemid 40767627)
4. Soriano V, Nunez M, Sanchez-Conde M et al. Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4. Antivir Ther 2005; 10 (1): 167-70.
5. De Cock L, Vranckx R. Serotyping and genotyping of hepatitis C virus in Belgium. Infection 2003; 31 (2): 92-7. (Pubitemid 36437722)
6. UNAIDS/WHO. United Nations report on the Global HIV/AID epidemics. UN AIDS Epidemic Update, 2002.
7. Galel SA, Strong DM, Tegtmeier GE et al. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays. Transfusion 2002; 42 (11): 1507-13.
8. Kirk GD, Lesi OA, Mendy M et al. The Gambia Liver Cancer Study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 2004; 39 (1): 211-9.
9. Ola SO, Otegbayo JA, Odaibo GN, Olaleye OD, Olubuyide OL. Serum hepatitis C virus and hepatitis B surface antigenaemia in Nigerian patients with acute icteric hepatitis. West Afr J Med 2002; 21 (3): 215-7.
10. Coursaget P, Bourdil C, Kastally R et al. Prevalence of hepatitis C virus infection in Africa: anti-HCV antibodies in the general population and in patients suffering from cirrhosis or primary liver cancer. Res Virol 1990; 141 (4): 449-54.
11. Ka MM, Herve P, Leguenno B et al. Low prevalence of anti-hepatitis C virus antibodies in hepatocellular carcinoma in Senegal. Ann Gastroenterol Hepatol (Paris) 1996; 31 (6): 329-32.
12. Aach RD, Stevens CE, Hollinger FB et al. Hepatitis C virus infection in post-transfusion hepatitis: an analysis with first- and second-generation assays. N Engl J Med 1991; 325 (19): 1325-9.
13. Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology 2002; 36 (5 Suppl 1): S99-105.
14. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20 (1): 1-16. (Pubitemid 30421405)
15. Guadagnino V, Stroffolini T, Rapicetta M et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997; 26 (4): 1006-11.
16. Passos EP, Silveira TR, Salazar CC et al. Hepatitis C virus infection and assisted reproduction. Hum Reprod 2002; 17 (8): 2085-8.
17. Hyder Q, Burhan-ul-Haq M, Rashid R, Qazi S, Mehmood S, Hadi SF. Non-conventional transmission of hepatitis C: a true possibility ignored. J Pak Med Assoc 2009; 59 (7): 430-3.
18. Fletcher S. Sexual transmission of hepatitis C and early intervention. J Assoc Nurses AIDS Care 2003; 14 (5 Suppl): 87S-94S. (Pubitemid 38552990)
19. Bortolotti F, Resti M, Giacchino R et al. Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. J Pediatr 1997; 130: 990-3.
20. Chen M, Xia S. A prevalence study on hepatitis C infection in 4055 healthy children of Beijing (in Chinese). Zhonghua Yu Fang Yi Xue Za Zhi 1999; 33 (3): 158-9.
21. Candotti D, Temple J, Sarkodie F, Allain JP. Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol 2003; 77 (14): 7914-23.
22. Mellors, JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272 (5265): 1167-70. (Pubitemid 26001148)
23. Jeannel D, Fretz C, Traore Y et al. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J Med Virol 1998; 55 (2): 92-7.
24. Songsivilai S, Kanistanon D, Dharakul T. A serotyping assay for hepatitis C virus in Southeast Asia. Clin Diagn Lab Immunol 1998; 5 (5): 737-9. (Pubitemid 29030774)
25. Dodig M, Tavill AS. Hepatitis C and human immunodeficiency virus reinfections. J Clin Gastroenterol 2001; 33 (5): 367-74.
26. Yoo TW, Donfield S, Lail A, Lynn HS, Daar ES; Hemophilia Growth and Development Study. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J Infect Dis 2005; 191 (1): 4-10.